Two new cyclopeptides from C. Y. Wu.

Nat Prod Res

College of Pharmacy, Guilin Medical University, Guilin, People's Republic of China.

Published: September 2024

Two new cyclic peptides, named as cyclogeobomptides A () and B () were isolated from the roots of C. Y. Wu. Compounds and are both made up of eight amino acids. The structures of them were established on the basis of the spectral data, including mass spectrometry, 2D NMR, and X-ray crystallography. Cyclogeobomptides A and B were proved to have obvious inhibitory activities against -glucosidase with the IC values of 26.00 and 19.16 M, respectively.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14786419.2023.2201883DOI Listing

Publication Analysis

Top Keywords

cyclopeptides cyclic
4
cyclic peptides
4
peptides named
4
named cyclogeobomptides
4
cyclogeobomptides isolated
4
isolated roots
4
roots compounds
4
compounds amino
4
amino acids
4
acids structures
4

Similar Publications

Didemnins, a class of cyclic depsipeptides derived from marine organisms exhibit notable anticancer properties. Among them, Didemnin B has been extensively researched for its strong antitumor activity and progression to clinical trials. Nonetheless, its clinical application has been impeded by challenges like poor bioavailability and dose-limiting toxicity.

View Article and Find Full Text PDF

Hyperuricemia, a disorder of purine metabolism associated with cardiovascular disease, gout, and kidney disease, can be alleviated by food-derived peptides. However, the precise mechanisms remain unclear, hindering their development. This study reviews uric acid-lowering peptides from various sources, focusing on two pathways: inhibiting uric acid production and promoting excretion.

View Article and Find Full Text PDF

cyclic lipopeptides (CLP), part of the three main families-surfactins, iturins, and fengycins-are secondary metabolites with a unique chemical structure that includes both peptide and lipid components. Being amphiphilic compounds, CLPs exhibit antimicrobial activity in vitro, damaging the membranes of microorganisms. However, the concentrations of CLPs used in vitro are difficult to achieve in natural conditions.

View Article and Find Full Text PDF

Genesis and regulation of C-terminal cyclic imides from protein damage.

Proc Natl Acad Sci U S A

January 2025

Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138.

C-Terminal cyclic imides are posttranslational modifications that can arise from spontaneous intramolecular cleavage of asparagine or glutamine residues resulting in a form of irreversible protein damage. These protein damage events are recognized and removed by the E3 ligase substrate adapter cereblon (CRBN), indicating that these aging-related modifications may require cellular quality control mechanisms to prevent deleterious effects. However, the factors that determine protein or peptide susceptibility to C-terminal cyclic imide formation or their effect on protein stability have not been explored in detail.

View Article and Find Full Text PDF

Vascular smooth muscle cell (SMC) relaxation by guanylyl cyclases (GCs) and cGMP is mediated by NO and its receptor soluble GC (sGC) or natriuretic peptides (NPs) ANP/BNP and CNP with the receptors GC-A and GC-B, respectively. It is commonly accepted that cultured SMCs differ from those in intact vessels. Nevertheless, cell culture often remains the first step for signaling investigations and drug testing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!